venBio Select Advisor »

Moonlake Immunot shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $156M 2.6M 60.39
2023-09-30 $114M 2.0M 57.00
2023-06-30 $88M 1.7M 51.00

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot